Page 1 | Search Results | Diabetes Care | American Diabetes Association

1-20 of 26

Sort by

Sort Order Select

Journal Articles

β-Cell Mass and Turnover in Humans: Effects of obesity and aging

Yoshifumi Saisho, MD, Alexandra E. Butler, MD, Erica Manesso, PHD, David Elashoff, PHD, Robert A. Rizza, MD, Peter C. Butler, MD

Diabetes Care 2013;36(1):111–117

https://doi.org/10.2337/dc12-0421

Published: 11 December 2012

View article titled, β-Cell Mass and Turnover in Humans: <subtitle>Effects of obesity and aging</subtitle>

Includes: Supplementary data

Journal Articles

Impaired Glycemia and Diabetic Polyneuropathy: The OC IG Survey

Peter J. Dyck, MD, Vicki M. Clark, CRA, Carol J. Overland, CRA, Jenny L. Davies, BA, John M. Pach, MD, P. James B. Dyck, MD, Christopher J. Klein, MD, Robert A. Rizza, MD, L. Joseph Melton, III, MD, Rickey E. Carter, PHD, Ronald Klein, MD, William J. Litchy, MD

Diabetes Care 2012;35(3):584–591

https://doi.org/10.2337/dc11-1421

Published: 10 February 2012

View article titled, Impaired Glycemia and Diabetic Polyneuropathy: <subtitle>The OC IG Survey</subtitle>

Includes: Supplementary data

Journal Articles

Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: A pilot study

Airani Sathananthan, MD, Chiara Dalla Man, PHD, Francesco Micheletto, MSC, Alan R. Zinsmeister, PHD, Michael Camilleri, MD, Paula D. Giesler, RN, Jeanette M. Laugen, Gianna Toffolo, PHD, Robert A. Rizza, MD, Claudio Cobelli, PHD, Adrian Vella, MD

Diabetes Care 2010;33(9):2074–2076

https://doi.org/10.2337/dc10-0200

Published: 01 September 2010

View article titled, Common Genetic Variation in <em>GLP1R</em> and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: <subtitle>A pilot study</subtitle>

Includes: Supplementary data

Journal Articles

Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness, and Postprandial Glucose Metabolism

Ananda Basu, MD, Chiara Dalla Man, PHD, Rita Basu, MD, Gianna Toffolo, PHD, Claudio Cobelli, PHD, Robert A. Rizza, MD

Diabetes Care 2009;32(5):866–872

https://doi.org/10.2337/dc08-1826

Published: 05 February 2009

View article titled, Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness, and Postprandial Glucose Metabolism

Includes: Supplementary data

Journal Articles

Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes

Chiara Dalla Man, PHD, Gerlies Bock, MD, Paula D. Giesler, RN, Denise B. Serra, PHARMD, Monica Ligueros Saylan, MD, James E. Foley, PHD, Michael Camilleri, MD, Gianna Toffolo, PHD, Claudio Cobelli, PHD, Robert A. Rizza, MD, Adrian Vella, MD

Diabetes Care 2009;32(1):14–18

https://doi.org/10.2337/dc08-1512

Published: 01 January 2009

View article titled, Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes

Journal Articles

Prandial Insulin and the Systemic Appearance of Meal-Derived Glucose in People With Type 1 Diabetes

Adrian Vella, MD, Pankaj Shah, MD, Ananda Basu, MD, Robert A. Rizza, MD

Diabetes Care 2008;31(11):2230–2231

https://doi.org/10.2337/dc08-1549

Published: 01 November 2008

View article titled, Prandial Insulin and the Systemic Appearance of Meal-Derived Glucose in People With Type 1 Diabetes

Journal Articles

Effect of 2 Years of Testosterone Replacement on Insulin Secretion, Insulin Action, Glucose Effectiveness, Hepatic Insulin Clearance, and Postprandial Glucose Turnover in Elderly Men

Rita Basu, MD, Chiara Dalla Man, PHD, Marco Campioni, PHD, Ananda Basu, MD, K. Sreekumaran Nair, MD, PHD, Michael D. Jensen, MD, Sundeep Khosla, MD, George Klee, MD, PHD, Gianna Toffolo, PHD, Claudio Cobelli, PHD, Robert A. Rizza, MD

Diabetes Care 2007;30(8):1972–1978

https://doi.org/10.2337/dc07-0359

Published: 01 August 2007

View article titled, Effect of 2 Years of Testosterone Replacement on Insulin Secretion, Insulin Action, Glucose Effectiveness, Hepatic Insulin Clearance, and Postprandial Glucose Turnover in Elderly Men

Includes: Supplementary data

Journal Articles

Progression From Newly Acquired Impaired Fasting Glucose to Type 2 Diabetes: Response to Nichols et al.

Sean F. Dinneen, MD, Robert A. Rizza, MD

Diabetes Care 2007;30(7):e79

https://doi.org/10.2337/dc07-0530

Published: 01 July 2007

View article titled, Progression From Newly Acquired Impaired Fasting Glucose to Type 2 Diabetes: <subtitle>Response to Nichols et al.</subtitle>

Journal Articles

Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes: Response to Orchard et al.

Peter J. Dyck, MD, Jenny L. Davies, BA, Vicki M. Clark, CCRP, William J. Litchy, MD, P. James B. Dyck, MD, Christopher J. Klein, MD, Robert A. Rizza, MD, John M. Pach, MD, Ronald Klein, MD, Timothy S. Larson, MD, L. Joseph Melton, III, MD, Peter C. O’Brien, PHD

Diabetes Care 2007;30(2):448–449

https://doi.org/10.2337/dc06-2239

Published: 01 February 2007

View article titled, Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes: <subtitle>Response to Orchard et al.</subtitle>

Journal Articles

Prediction of Postprandial Glycemic Exposure: Utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength

Ohad Cohen, MD, Rita Basu, MD, Gerlies Bock, MD, Chiara Dalla Man, PHD, Marco Campioni, PHD, Ananda Basu, MD, Gianna Toffolo, PHD, Claudio Cobelli, PHD, Robert A. Rizza, MD

Diabetes Care 2006;29(12):2708–2713

https://doi.org/10.2337/dc06-1118

Published: 01 December 2006

View article titled, Prediction of Postprandial Glycemic Exposure: <subtitle>Utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength</subtitle>

Journal Articles

Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes

Peter J. Dyck, MD, Jenny L. Davies, BA, Vicki M. Clark, William J. Litchy, MD, P. James B. Dyck, MD, Christopher J. Klein, MD, Robert A. Rizza, MD, John M. Pach, MD, Ronald Klein, MD, Timothy S. Larson, MD, L. Joseph Melton, III, MD, Peter C. O’Brien, PHD

Diabetes Care 2006;29(10):2282–2288

https://doi.org/10.2337/dc06-0525

Published: 01 October 2006

View article titled, Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes

Journal Articles

Preventing Cardiovascular Disease and Diabetes: A call to action from the American Diabetes Association and the American Heart Association

Robert H. Eckel, MD, Richard Kahn, PHD, Rose Marie Robertson, MD, Robert A. Rizza, MD

Diabetes Care 2006;29(7):1697–1699

https://doi.org/10.2337/dc06-9911

Published: 01 July 2006

View article titled, Preventing Cardiovascular Disease and Diabetes: <subtitle>A call to action from the American Diabetes Association and the American Heart Association</subtitle>

Journal Articles

Effects of Pioglitazone Versus Glipizide on Body Fat Distribution, Body Water Content, and Hemodynamics in Type 2 Diabetes

Ananda Basu, MD, Michael D. Jensen, MD, Frances McCann, PHD, Debabrata Mukhopadhyay, PHD, Michael J. Joyner, MD, Robert A. Rizza, MD

Diabetes Care 2006;29(3):510–514

https://doi.org/10.2337/diacare.29.03.06.dc05-2004

Published: 01 March 2006

View article titled, Effects of Pioglitazone Versus Glipizide on Body Fat Distribution, Body Water Content, and Hemodynamics in Type 2 Diabetes

Journal Articles

Relationship Between β-Cell Mass and Fasting Blood Glucose Concentration in Humans

Robert A. Ritzel, MD, Alexandra E. Butler, MD, Robert A. Rizza, MD, Johannes D. Veldhuis, MD, Peter C. Butler, MD

Diabetes Care 2006;29(3):717–718

https://doi.org/10.2337/diacare.29.03.06.dc05-1538

Published: 01 March 2006

View article titled, Relationship Between β-Cell Mass and Fasting Blood Glucose Concentration in Humans

Journal Articles

Randomized Controlled Clinical Trial of Glargine Versus Ultralente Insulin in the Treatment of Type 1 Diabetes

Yogish C. Kudva, MD, MBBS, Ananda Basu, MD, Gregory D. Jenkins, MS, Guillermo M. Pons, MD, Lori L. Quandt, RN, Julie A. Gebel, RN, Debra A. Vogelsang, NP, Steven A. Smith, MD, Robert A. Rizza, MD, William L. Isley, MD

Diabetes Care 2005;28(1):10–14

https://doi.org/10.2337/diacare.28.1.10

Published: 01 January 2005

View article titled, Randomized Controlled Clinical Trial of Glargine Versus Ultralente Insulin in the Treatment of Type 1 Diabetes

Journal Articles

A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020

Robert A. Rizza, MD, Robert A. Vigersky, MD, Helena W. Rodbard, MD, Paul W. Ladenson, MD, William F. Young, Jr., MD, Martin I. Surks, MD, Richard Kahn, PHD, Paul F. Hogan, PHD(ABD)

Diabetes Care 2003;26(5):1545–1552

https://doi.org/10.2337/diacare.26.5.1545

Published: 01 May 2003

View article titled, A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020

Journal Articles

The Impact of Planned Care and a Diabetes Electronic Management System on Community-Based Diabetes Care: The Mayo Health System Diabetes Translation Project

Victor M. Montori, MD, MSC, Sean F. Dinneen, MD, Colum A. Gorman, MD, Bruce R. Zimmerman, MD, Robert A. Rizza, MD, Susan S. Bjornsen, RD, CDE, Erin M. Green, Sandra C. Bryant, MS, Steven A. Smith, MD, for The Translation Project Investigator Group

Diabetes Care 2002;25(11):1952–1957

https://doi.org/10.2337/diacare.25.11.1952

Published: 01 November 2002

View article titled, The Impact of Planned Care and a Diabetes Electronic Management System on Community-Based Diabetes Care: <subtitle>The Mayo Health System Diabetes Translation Project </subtitle>

Journal Articles

Effects of Changing Diagnostic Criteria on the Risk of Developing Diabetes

Sean F Dinneen, MD, MSC, David Maldonado, III, Cynthia L Leibson, PHD, George G Klee, MD, Hongzhe Li, PHD, L Joseph Melton, III, MD, Robert A Rizza, MD

Diabetes Care 1998;21(9):1408–1413

https://doi.org/10.2337/diacare.21.9.1408

Published: 01 September 1998

View article titled, Effects of Changing Diagnostic Criteria on the Risk of Developing Diabetes

Journal Articles

Impact of a Diabetes Electronic Management System on the Care of Patients Seen in a Subspecialty Diabetes Clinic

Steven A Smith, MD, Mary E Murphy, RN, Todd R Huschka, BS, Sean F Dinneen, MD, Colum A Gorman, MD, Bruce R Zimmerman, MD, Robert A Rizza, MD, James M Naessens, MPH

Diabetes Care 1998;21(6):972–976

https://doi.org/10.2337/diacare.21.6.972

Published: 01 June 1998

View article titled, Impact of a Diabetes Electronic Management System on the Care of Patients Seen in a Subspecialty Diabetes Clinic

Journal Articles

The Classification of Diabetes by Clinical and C-Peptide Criteria: A prospective population-based study

F John Service, MD, PHD, Robert A Rizza, MD, Bruce R Zimmerman, MD, Peter J Dyck, MD, Peter C O'Brien, PHD, L Joseph Melton, III, MD

Diabetes Care 1997;20(2):198–201

https://doi.org/10.2337/diacare.20.2.198

Published: 01 February 1997

View article titled, The Classification of Diabetes by Clinical and C-Peptide Criteria: A prospective population-based study

NARROW

β-Cell Mass and Turnover in Humans: Effects of obesity and aging

Impaired Glycemia and Diabetic Polyneuropathy: The OC IG Survey

Common Genetic Variation in GLP1R and Insulin Secretion in Response to Exogenous GLP-1 in Nondiabetic Subjects: A pilot study

Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness, and Postprandial Glucose Metabolism

Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes

Prandial Insulin and the Systemic Appearance of Meal-Derived Glucose in People With Type 1 Diabetes

Effect of 2 Years of Testosterone Replacement on Insulin Secretion, Insulin Action, Glucose Effectiveness, Hepatic Insulin Clearance, and Postprandial Glucose Turnover in Elderly Men

Progression From Newly Acquired Impaired Fasting Glucose to Type 2 Diabetes: Response to Nichols et al.

Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes: Response to Orchard et al.

Prediction of Postprandial Glycemic Exposure: Utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength

Modeling Chronic Glycemic Exposure Variables as Correlates and Predictors of Microvascular Complications of Diabetes

Preventing Cardiovascular Disease and Diabetes: A call to action from the American Diabetes Association and the American Heart Association

Effects of Pioglitazone Versus Glipizide on Body Fat Distribution, Body Water Content, and Hemodynamics in Type 2 Diabetes

Relationship Between β-Cell Mass and Fasting Blood Glucose Concentration in Humans

Randomized Controlled Clinical Trial of Glargine Versus Ultralente Insulin in the Treatment of Type 1 Diabetes

A Model to Determine Workforce Needs for Endocrinologists in the United States Until 2020

The Impact of Planned Care and a Diabetes Electronic Management System on Community-Based Diabetes Care: The Mayo Health System Diabetes Translation Project

Effects of Changing Diagnostic Criteria on the Risk of Developing Diabetes

Impact of a Diabetes Electronic Management System on the Care of Patients Seen in a Subspecialty Diabetes Clinic

The Classification of Diabetes by Clinical and C-Peptide Criteria: A prospective population-based study

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only